Table of Content

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF GLOBAL RADIOFREQUENCY DEVICES MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATION

1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 KEY TAKEAWAYS

2.2 ARRIVING AT THE GLOBAL RADIOFREQUENCY DEVICES MARKET SIZE

2.2.1 VENDOR POSITIONING GRID

2.2.2 TECHNOLOGY LIFE LINE CURVE

2.2.3 TRIPOD DATA VALIDATION MODEL

2.2.4 MARKET GUIDE

2.2.5 MULTIVARIATE MODELLING

2.2.6 TOP TO BOTTOM ANALYSIS

2.2.7 CHALLENGE MATRIX

2.2.8 APPLICATION COVERAGE GRID

2.2.9 STANDARDS OF MEASUREMENT

2.2.10 VENDOR SHARE ANALYSIS

2.2.11 DATA POINTS FROM KEY PRIMARY INTERVIEWS

2.2.12 DATA POINTS FROM KEY SECONDARY DATABASES

2.3 GLOBAL RADIOFREQUENCY DEVICES MARKET: RESEARCH SNAPSHOT

2.4 ASSUMPTIONS

3 MARKET OVERVIEW

3.1 DRIVERS

3.2 RESTRAINTS

3.3 OPPORTUNITIES

3.4 CHALLENGES

4 EXECUTIVE SUMMARY

5 PREMIUM INSIGHTS

5.1 PESTEL ANALYSIS

5.2 PORTER’S FIVE FORCES MODEL

6 INDUSTRY INSIGHTS

6.1 MICRO AND MACRO ECONOMIC FACTORS

6.2 PENETRATION AND GROWTH PROSPECT MAPPING

6.3 KEY PRICING STRATEGIES

6.4 INTERVIEWS WITH SPECIALIST

6.5 ANALYIS AND RECOMMENDATION

7 INTELLECTUAL PROPERTY (IP) PORTFOLIO

7.1 PATENT QUALITY AND STRENGTH

7.2 PATENT FAMILIES

7.3 LICENSING AND COLLABORATIONS

7.4 COMPETITIVE LANDSCAPE

7.5 IP STRATEGY AND MANAGEMENT

7.6 OTHER

8 COST ANALYSIS BREAKDOWN

9 TECHNONLOGY ROADMAP

10 INNOVATION TRACKER AND STRATEGIC ANALYSIS

10.1 MAJOR DEALS AND STRATEGIC ALLIANCES ANALYSIS

10.1.1 JOINT VENTURES

10.1.2 MERGERS AND ACQUISITIONS

10.1.3 LICENSING AND PARTNERSHIP

10.1.4 TECHNOLOGY COLLABORATIONS

10.1.5 STRATEGIC DIVESTMENTS

10.2 NUMBER OF PRODUCTS IN DEVELOPMENT

10.3 STAGE OF DEVELOPMENT

10.4 TIMELINES AND MILESTONES

10.5 INNOVATION STRATEGIES AND METHODOLOGIES

10.6 RISK ASSESSMENT AND MITIGATION

10.7 FUTURE OUTLOOK

11 REGULATORY COMPLIANCE

11.1 REGULATORY AUTHORITIES

11.2 REGULATORY CLASSIFICATIONS

11.2.1 CLASS I

11.2.2 CLASS II

11.2.3 CLASS III

11.3 REGULATORY SUBMISSIONS

11.4 INTERNATIONAL HARMONIZATION

11.5 COMPLIANCE AND QUALITY MANAGEMENT SYSTEMS

11.6 REGULATORY CHALLENGES AND STRATEGIES

12 REIMBURSEMENT FRAMEWORK

13 OPPUTUNITY MAP ANALYSIS

14 VALUE CHAIN ANALYSIS

15 HEALTHCARE ECONOMY

15.1 HEALTHCARE EXPENDITURE

15.2 CAPITAL EXPENDITURE

15.3 CAPEX TRENDS

15.4 CAPEX ALLOCATION

15.5 FUNDING SOURCES

15.6 INDUSTRY BENCHMARKS

15.7 GDP RATION IN OVERALL GDP

15.8 HEALTHCARE SYSTEM STRUCTURE

15.9 GOVERNMENT POLICIES

15.1 ECONOMIC DEVELOPMENT

16 GLOBAL RADIOFREQUENCY DEVICES MARKET, BY TYPE

16.1 OVERVIEW

16.2 UNIPOLAR RADIOFREQUENCY ABLATION

16.3 BIPOLAR RADIOFREQUENCY ABLATION

17 GLOBAL RADIOFREQUENCY DEVICES MARKET, BY PRODUCT

17.1 OVERVIEW

17.2 CAPITAL EQUIPMENT

17.2.1 BY TYPE

17.2.1.1. TEMPERATURE-CONTROLLED RADIOFREQUENCY ABLATORS

17.2.1.2. FLUID-COOLED RADIOFREQUENCY ABLATORS

17.2.1.3. ROBOTIC CATHETER MANIPULATION SYSTEMS

17.2.1.4. OTHERS

17.2.2 BY MODALITY

17.2.2.1. STANDALONE

17.2.2.2. PORTABLE

17.2.2.3. BENCHTOP

17.2.2.4. HANDHELD

17.2.3 BY PROCEDURE TYPE

17.2.3.1. NON-INVASIVE RF DEVICE

17.2.3.2. MINIMALLY INVASIVE RF DEVICES

17.2.3.3. INVASIVE RF DEVICES

17.2.4 BY FREQUENCY

17.2.4.1. LOW-FREQUENCY RF DEVICES

17.2.4.2. HIGH-FREQUENCY RF DEVICES

17.2.5 OTHERS

17.3 REUSABLE EQUIPMENT

17.3.1 RF ELECTRODE

17.3.1.1. RF ABLATION SINGLE ELECTRODE KITS

17.3.1.2. RF ABLATION CLUSTER ELECTRODE KITS

17.3.1.3. RF ABLATION SWITCHING ELECTRODE KITS

17.3.1.4. RF ABLATION MULTIPLE ELECTRODE KITS

17.3.2 RF ABLATION PROBES

17.3.2.1. STERILE

17.3.2.2. NON-STERILE

17.3.3 RF ABLATION SYSTEM GROUNDING PAD

17.3.4 RF ABLATION SYSTEM EXTENSION CABLE

17.3.5 PATIENT-SPECIFIC ATTACHMENTS

17.3.6 CONDUCTIVE TIPS

17.3.7 HANDPIECES

17.3.8 OTHERS

17.4 DISPOSABLES

17.4.1 RF CANNULA

17.4.2 RF NEEDLES

17.4.3 RF CATHETERS

17.4.4 OTHERS

18 GLOBAL RADIOFREQUENCY DEVICES MARKET, BY PORTABILITY

18.1 OVERVIEW

18.2 STANDALONE

18.3 PORTABLE

18.4 BENCHTOP

18.5 HANDHELD

19 GLOBAL RADIOFREQUENCY DEVICES MARKET, BY APPLICATION

19.1 OVERVIEW

19.2 CARDIOLOGY

19.2.1 ATRIAL FIBRILLATION

19.2.2 ATRIAL FLUTTER

19.2.3 ATRIOVENTRICULAR NODAL REENTRY TACHYCARDIA (AVNRT)

19.2.4 WOLFF-PARKINSON-WHITE SYNDROME (WPW)

19.2.5 OTHERS

19.3 ONCOLOGY

19.3.1 LIVER CANCER

19.3.2 KIDNEY CANCER

19.3.3 PROSTATE CANCER

19.3.4 LUNG CANCER

19.3.5 BONE METASTASIS

19.3.6 BREAST CANCER

19.3.7 OTHERS

19.4 ARRHYTHMIA

19.5 OBSTRUCTIVE SLEEP APNEA

19.6 PAIN MANAGEMENT

19.7 DERMATOLOGY

19.8 AESTHETIC AND COSMETIC

19.8.1 ACNE SCARS

19.8.2 STRETCH MARKS

19.8.3 SKIN TONNING

19.8.4 REFINES SKIN TEXTURE

19.8.5 PORES TIGHTENING

19.8.6 REDUCES AND SMOOTHS POST-OPERATIVE SCARS

19.8.7 REDUCES & SMOOTHES FINE LINES AND WRINKLES

19.8.8 FADES HYPERPIGMENTATION (PREGNANCY MASK & SUNSPOTS)

19.8.9 OTHERS

19.9 GYNECOLOGY

19.1 OTHERS

20 GLOBAL RADIOFREQUENCY DEVICES MARKET, BY END USER

20.1 OVERVIEW

20.2 HOSPITALS

20.2.1 BY TYPE

20.2.1.1. PRIVATE

20.2.1.2. PUBLIC

20.2.2 BY LEVEL

20.2.2.1. TIER 1

20.2.2.2. TIER 2

20.2.2.3. TIER 3

20.3 MEDICAL SPAS

20.4 SPECIALTY CLINICS

20.5 CLINICAL LABORATORIES

20.6 CANCER RESEARCH INSTITUTES

20.7 CATHERIZATION LABORATORIES

20.8 AMBULATORY SURGICAL CENTERS

20.9 AESTHETIC AND COSMETIC CLINICS

20.1 OTHERS

21 GLOBAL RADIOFREQUENCY DEVICES MARKET, BY DISTRIBUTION CHANNEL

21.1 OVERVIEW

21.2 DIRECT TENDER

21.3 RETAIL SALES

21.3.1 ONLINE SALES

21.3.2 OFFLINE SALES

21.4 OTHERS

22 GLOBAL RADIOFREQUENCY DEVICES MARKET, COMPANY LANDSCAPE

22.1 COMPANY SHARE ANALYSIS: GLOBAL

22.2 COMPANY SHARE ANALYSIS: NORTH AMERICA

22.3 COMPANY SHARE ANALYSIS: EUROPE

22.4 COMPANY SHARE ANALYSIS: ASIA PACIFIC

22.5 MERGERS & ACQUISITIONS

22.6 NEW PRODUCT DEVELOPMENT & APPROVALS

22.7 EXPANSIONS

22.8 REGULATORY CHANGES

22.9 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS

23 GLOBAL RADIOFREQUENCY DEVICES MARKET, BY GEOGRAPHY

GLOBAL RADIOFREQUENCY DEVICES MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)

23.1 NORTH AMERICA

23.1.1 U.S.

23.1.2 CANADA

23.1.3 MEXICO

23.2 EUROPE

23.2.1 GERMANY

23.2.2 FRANCE

23.2.3 U.K.

23.2.4 ITALY

23.2.5 SPAIN

23.2.6 RUSSIA

23.2.7 TURKEY

23.2.8 BELGIUM

23.2.9 NETHERLANDS

23.2.10 SWITZERLAND

23.2.11 DENMARK

23.2.12 NORWAY

23.2.13 SWEDEN

23.2.14 FINLAND

23.2.15 POLAND

23.2.16 REST OF EUROPE

23.3 ASIA-PACIFIC

23.3.1 JAPAN

23.3.2 CHINA

23.3.3 SOUTH KOREA

23.3.4 INDIA

23.3.5 AUSTRALIA

23.3.6 SINGAPORE

23.3.7 THAILAND

23.3.8 MALAYSIA

23.3.9 INDONESIA

23.3.10 PHILIPPINES

23.3.11 VIETNAM

23.3.12 NEW ZEALAND

23.3.13 TAIWAN

23.3.14 REST OF ASIA-PACIFIC

23.4 SOUTH AMERICA

23.4.1 BRAZIL

23.4.2 ARGENTINA

23.4.3 REST OF SOUTH AMERICA

23.5 MIDDLE EAST AND AFRICA

23.5.1 SOUTH AFRICA

23.5.2 SAUDI ARABIA

23.5.3 UAE

23.5.4 EGYPT

23.5.5 ISRAEL

23.5.6 OMAN

23.5.7 QATAR

23.5.8 BAHRAIN

23.5.9 REST OF MIDDLE EAST AND AFRICA

23.6 KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES

24 GLOBAL RADIOFREQUENCY DEVICES MARKET, SWOT AND DBMR ANALYSIS

25 GLOBAL RADIOFREQUENCY DEVICES MARKET, COMPANY PROFILE

25.1 ANGIODYNAMICS, INC.

25.1.1 COMPANY OVERVIEW

25.1.2 REVENUE ANALYSIS

25.1.3 GEOGRAPHIC PRESENCE

25.1.4 PRODUCT PORTFOLIO

25.1.5 RECENT DEVELOPMENTS

25.2 ARTHREX, INC

25.2.1 COMPANY OVERVIEW

25.2.2 REVENUE ANALYSIS

25.2.3 GEOGRAPHIC PRESENCE

25.2.4 PRODUCT PORTFOLIO

25.2.5 RECENT DEVELOPMENTS

25.3 BOSTON SCIENTIFIC CORPORATION

25.3.1 COMPANY OVERVIEW

25.3.2 REVENUE ANALYSIS

25.3.3 GEOGRAPHIC PRESENCE

25.3.4 PRODUCT PORTFOLIO

25.3.5 RECENT DEVELOPMENTS

25.4 ETHICON INC

25.4.1 COMPANY OVERVIEW

25.4.2 REVENUE ANALYSIS

25.4.3 GEOGRAPHIC PRESENCE

25.4.4 PRODUCT PORTFOLIO

25.4.5 RECENT DEVELOPMENTS

25.5 KONINKLIJKE PHILIPS N.V.

25.5.1 COMPANY OVERVIEW

25.5.2 REVENUE ANALYSIS

25.5.3 GEOGRAPHIC PRESENCE

25.5.4 PRODUCT PORTFOLIO

25.5.5 RECENT DEVELOPMENTS

25.6 BLOOMEA

25.6.1 COMPANY OVERVIEW

25.6.2 REVENUE ANALYSIS

25.6.3 GEOGRAPHIC PRESENCE

25.6.4 PRODUCT PORTFOLIO

25.6.5 RECENT DEVELOPMENTS

25.7 MEDTRONIC

25.7.1 COMPANY OVERVIEW

25.7.2 REVENUE ANALYSIS

25.7.3 GEOGRAPHIC PRESENCE

25.7.4 PRODUCT PORTFOLIO

25.7.5 RECENT DEVELOPMENTS

25.8 SUTTER MEDIZINTECHNIK GMBH

25.8.1 COMPANY OVERVIEW

25.8.2 REVENUE ANALYSIS

25.8.3 GEOGRAPHIC PRESENCE

25.8.4 PRODUCT PORTFOLIO

25.8.5 RECENT DEVELOPMENTS

25.9 BVM MEDICAL

25.9.1 COMPANY OVERVIEW

25.9.2 REVENUE ANALYSIS

25.9.3 GEOGRAPHIC PRESENCE

25.9.4 PRODUCT PORTFOLIO

25.9.5 RECENT DEVELOPMENTS

25.1 STRYKER

25.10.1 COMPANY OVERVIEW

25.10.2 REVENUE ANALYSIS

25.10.3 GEOGRAPHIC PRESENCE

25.10.4 PRODUCT PORTFOLIO

25.10.5 RECENT DEVELOPMENTS

25.11 ADVANCED MICROSYSTEMS TECHNOLOGIES - A DIVISION OF SANMINA CORPORATION

25.11.1 COMPANY OVERVIEW

25.11.2 REVENUE ANALYSIS

25.11.3 GEOGRAPHIC PRESENCE

25.11.4 PRODUCT PORTFOLIO

25.11.5 RECENT DEVELOPMENTS

25.12 ATRICURE, INC.

25.12.1 COMPANY OVERVIEW

25.12.2 REVENUE ANALYSIS

25.12.3 GEOGRAPHIC PRESENCE

25.12.4 PRODUCT PORTFOLIO

25.12.5 RECENT DEVELOPMENTS

25.13 OLYMPUS

25.13.1 COMPANY OVERVIEW

25.13.2 REVENUE ANALYSIS

25.13.3 GEOGRAPHIC PRESENCE

25.13.4 PRODUCT PORTFOLIO

25.13.5 RECENT DEVELOPMENTS

25.14 BAYLIS MEDICAL COMPANY INC.

25.14.1 COMPANY OVERVIEW

25.14.2 REVENUE ANALYSIS

25.14.3 GEOGRAPHIC PRESENCE

25.14.4 PRODUCT PORTFOLIO

25.14.5 RECENT DEVELOPMENTS

25.15 NOVOMED

25.15.1 COMPANY OVERVIEW

25.15.2 REVENUE ANALYSIS

25.15.3 GEOGRAPHIC PRESENCE

25.15.4 PRODUCT PORTFOLIO

25.15.5 RECENT DEVELOPMENTS

25.16 SIEMENS HEALTHCARE PRIVATE LIMITED

25.16.1 COMPANY OVERVIEW

25.16.2 REVENUE ANALYSIS

25.16.3 GEOGRAPHIC PRESENCE

25.16.4 PRODUCT PORTFOLIO

25.16.5 RECENT DEVELOPMENTS

25.17 BD

25.17.1 COMPANY OVERVIEW

25.17.2 REVENUE ANALYSIS

25.17.3 GEOGRAPHIC PRESENCE

25.17.4 PRODUCT PORTFOLIO

25.17.5 RECENT DEVELOPMENTS

25.18 INTEGER HOLDINGS CORPORATION

25.18.1 COMPANY OVERVIEW

25.18.2 REVENUE ANALYSIS

25.18.3 GEOGRAPHIC PRESENCE

25.18.4 PRODUCT PORTFOLIO

25.18.5 RECENT DEVELOPMENTS

25.19 TELEFLEX INCORPORATED.

25.19.1 COMPANY OVERVIEW

25.19.2 REVENUE ANALYSIS

25.19.3 GEOGRAPHIC PRESENCE

25.19.4 PRODUCT PORTFOLIO

25.19.5 RECENT DEVELOPMENTS

25.2 TERUMO EUROPE NV

25.20.1 COMPANY OVERVIEW

25.20.2 REVENUE ANALYSIS

25.20.3 GEOGRAPHIC PRESENCE

25.20.4 PRODUCT PORTFOLIO

25.20.5 RECENT DEVELOPMENTS

25.21 ABBOTT

25.21.1 COMPANY OVERVIEW

25.21.2 REVENUE ANALYSIS

25.21.3 GEOGRAPHIC PRESENCE

25.21.4 PRODUCT PORTFOLIO

25.21.5 RECENT DEVELOPMENTS

25.22 AVNS

25.22.1 COMPANY OVERVIEW

25.22.2 REVENUE ANALYSIS

25.22.3 GEOGRAPHIC PRESENCE

25.22.4 PRODUCT PORTFOLIO

25.22.5 RECENT DEVELOPMENTS

25.23 F CARE SYSTEMS

25.23.1 COMPANY OVERVIEW

25.23.2 REVENUE ANALYSIS

25.23.3 GEOGRAPHIC PRESENCE

25.23.4 PRODUCT PORTFOLIO

25.23.5 RECENT DEVELOPMENTS

25.24 XCELLANCE MEDICAL TECHNOLOGIES PVT LTD

25.24.1 COMPANY OVERVIEW

25.24.2 REVENUE ANALYSIS

25.24.3 GEOGRAPHIC PRESENCE

25.24.4 PRODUCT PORTFOLIO

25.24.5 RECENT DEVELOPMENTS

25.25 BIOTRONIK SE & CO. KG

25.25.1 COMPANY OVERVIEW

25.25.2 REVENUE ANALYSIS

25.25.3 GEOGRAPHIC PRESENCE

25.25.4 PRODUCT PORTFOLIO

25.25.5 RECENT DEVELOPMENTS

25.26 STARMED CO., LTD.

25.26.1 COMPANY OVERVIEW

25.26.2 REVENUE ANALYSIS

25.26.3 GEOGRAPHIC PRESENCE

25.26.4 PRODUCT PORTFOLIO

25.26.5 RECENT DEVELOPMENTS

25.27 HOLOGIC, INC.

25.27.1 COMPANY OVERVIEW

25.27.2 REVENUE ANALYSIS

25.27.3 GEOGRAPHIC PRESENCE

25.27.4 PRODUCT PORTFOLIO

25.27.5 RECENT DEVELOPMENTS

25.28 OSYPKA AG

25.28.1 COMPANY OVERVIEW

25.28.2 REVENUE ANALYSIS

25.28.3 GEOGRAPHIC PRESENCE

25.28.4 PRODUCT PORTFOLIO

25.28.5 RECENT DEVELOPMENTS

25.29 MERIT MEDICAL SYSTEMS

25.29.1 COMPANY OVERVIEW

25.29.2 REVENUE ANALYSIS

25.29.3 GEOGRAPHIC PRESENCE

25.29.4 PRODUCT PORTFOLIO

25.29.5 RECENT DEVELOPMENTS

25.3 CONMED CORPORATION

25.30.1 COMPANY OVERVIEW

25.30.2 REVENUE ANALYSIS

25.30.3 GEOGRAPHIC PRESENCE

25.30.4 PRODUCT PORTFOLIO

25.30.5 RECENT DEVELOPMENTS

25.31 LUTRONIC CORPORATION

25.31.1 COMPANY OVERVIEW

25.31.2 REVENUE ANALYSIS

25.31.3 GEOGRAPHIC PRESENCE

25.31.4 PRODUCT PORTFOLIO

25.31.5 RECENT DEVELOPMENTS

26 RELATED REPORTS

27 CONCLUSION

28 QUESTIONNAIRE

29 ABOUT DATA BRIDGE MARKET RESEARCH